JW Pharmaceutical (XKRX:001067) Long-Term Debt: ₩0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:001067 JW Pharmaceutical XKRX:001067
85 GF Score
Price ₩48,900.00
GF Value ₩51,977.39
Valuation Fairly Valued
View Full Analysis

What is JW Pharmaceutical Long-Term Debt?

JW Pharmaceutical XKRX:001067 +0.31% 85 Long-Term Debt is ₩0 Mil as of Jun. 2026. GuruFocus rates XKRX:001067 with a GF Score™ of 85/100 and a GF Value™ of ₩51,977.39 (Fairly Valued).

JW Pharmaceutical's Long-Term Debt for the quarter that ended in Jun. 2026 was ₩0 Mil.

JW Pharmaceutical's annual Long-Term Debt declined from Dec. 2023 (₩30,000 Mil) to Dec. 2024 (₩25,102 Mil) and declined from Dec. 2024 (₩25,102 Mil) to Dec. 2025 (₩0 Mil).

JW Pharmaceutical  (XKRX:001067) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

JW Pharmaceutical Long-Term Debt Related Terms

JW Pharmaceutical Long-Term Debt Historical Data

* Premium members only.

The historical data trend for JW Pharmaceutical's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW Pharmaceutical Long-Term Debt Chart

JW Pharmaceutical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 120,743.64 0.00 30,000.00 25,102.03 0.00

JW Pharmaceutical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XKRX:001067
85GF Score
JW Pharmaceutical XKRX:001067
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₩0 Mil mean?
JW Pharmaceutical (XKRX:001067) has a Long-Term Debt of ₩0 Mil as of Jun. 2026.
Is JW Pharmaceutical's Long-Term Debt too high?
JW Pharmaceutical's current Long-Term Debt is ₩0 Mil. Overall, JW Pharmaceutical has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JW Pharmaceutical's Long-Term Debt compare to ZTS?
JW Pharmaceutical's Long-Term Debt of ₩0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. JW Pharmaceutical's current Long-Term Debt is ₩0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JW Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, JW Pharmaceutical (XKRX:001067) is currently considered Fairly Valued. The stock's GF Value™ is ₩51,977.39, compared to a current price of ₩48,900.00 — trading 5.9% below its estimated fair value. The current Long-Term Debt is ₩0 Mil. JW Pharmaceutical's overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For JW Pharmaceutical (XKRX:001067), the current Long-Term Debt is ₩0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JW Pharmaceutical (XKRX:001067) Overvalued in 2026?

Based on GuruFocus' analysis, JW Pharmaceutical stock appears to be undervalued. The current stock price of ₩48,900.00 is trading 5.9% below its estimated GF Value™ of ₩51,977.39. GuruFocus considers JW Pharmaceutical to be Fairly Valued.

Key valuation signals for XKRX:001067:

  • Long-Term Debt: ₩0 Mil
  • GF Value™: ₩51,977.39 vs. price of ₩48,900.00 (5.9% below fair value)
  • GF Score™: 85/100

No single metric tells the full story. See the XKRX:001067 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JW Pharmaceutical Business Description

Address 2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.
85GF Score

Get the complete analysis for XKRX:001067

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩48,900.00
Price
₩51,977.39
GF Value